MA-INTERVALZERO
Matrox Imaging and IntervalZero today announced Matrox Imaging Library (MIL) support for IntervalZero’s RTX64 Real-time Operating System (RTOS) Platform.
The result of close collaboration between the two companies, MIL for RTX64 gives OEMs of high-throughput, time- and response-critical machine vision sub-systems an alternative to using expensive, proprietary image-acquisition and processing hardware.
Guidance, inspection and identification applications can be deployed such that the demanding vision and control functions run in RTX64’s highly deterministic environment while the rest of the applications, such as the HMI and archiving operations, run in a familiar Windows environment on standard PCs.
Through a separate real-time scheduler, IntervalZero’s RTX64 real-time software transforms the Windows general-purpose operating system into a fully functional RTOS that runs entirely on x64 multicore hardware. The RTX64 scheduler uniquely enables embedded real-time applications to directly access the 512GB of addressable physical memory available on 64-bit Windows.
“Running the vision applications on RTX64 ensures that the mission-critical portion of the application responds in a predictable and consistent manner, delivering quality, performance and high throughput,” said Brian Calder, vice president, sales, for US-based IntervalZero. “MIL for RTX64 is the right solution for customers who need to implement vision within highly deterministic settings and do it all within the Windows development environment.”
“MIL is the first and only vision library to take advantage of IntervalZero’s ground-breaking real-time software,” said Sam Lopez, director sales and marketing, Matrox Imaging. “This introduction of MIL for RTX64 means that the most demanding machine vision applications can be implemented at a fraction of the previous cost. Proprietary real-time hardware can be replaced by software applications that run on standard PCs, without sacrificing performance or reliability.”
Visit Matrox Imaging at Vision 2014 (Stuttgart, Nov. 4-6, stand 1F21) to learn more.
About Matrox Imaging Library (MIL)
First released in 1993, Matrox Imaging Library (MIL) is a comprehensive collection of software tools for developing industrial imaging applications. MIL includes tools for every step in the process: from application feasibility, to prototyping, through to development and ultimately deployment. The toolkit features interactive software and programming functions for image capture, processing, analysis, annotation, display, and archiving. These tools are designed to enhance productivity, thereby reducing the time and effort required to bring machine vision solutions to market.
Availability
Early access to support for RTX64 is now available as an update to MIL 10. The update provides support for video capture using GigE Vision® cameras and selected Matrox Radient frame grabbers. Official release is planned for Q2 2015. More information can be obtained by contacting a local sales representative or imaging.info@matrox.com .
About Matrox Imaging
Established in 1976, Matrox Imaging is a leading developer of component-level solutions for machine vision, image analysis and medical imaging. Products include frame grabbers, vision processors, imaging computers, smart cameras and application development software.
Headquartered in Montreal, Quebec, Canada, Matrox is a privately held company with offices in the United Kingdom, Ireland, Germany and Hong Kong. For more information, visit www.matroximaging.com .
About IntervalZero
IntervalZero’s customer-centered philosophy, combined with more than three decades of embedded software innovation and the proven value of its RTX64 and RTX hard real-time software have enabled the company to build a global customer base of market-leading OEMs and end users in Industrial Automation, Medical Systems, Digital Media, Test & Measurement, Military & Aerospace, and other industries.
Headquartered in Massachusetts IntervalZero also has offices in Nice, France; Taipei, Taiwan; and Munich, Germany. For more information, visit www.intervalzero.com .
Matrox and Matrox product names are registered trademarks and/or trademarks of Matrox Electronic Systems, Ltd. and/or Matrox Graphics Inc. in Canada and/or other countries. All other company and product names are registered trademarks and/or trademarks of their respective owners.
Contact:
Matrox Media Contact:
Janet Matey, +1-514-822-6037
Media
Relations Manager
or
IntervalZero Media Contact:
Brian
Carter, +1-508-277-7570
VP, Strategic Communications
Link:
Information om Business Wire
Følg pressemeddelelser fra Business Wire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Business Wire
CCM Biosciences Announces Presentation of Data on its First-In-Class AML Drug Program at ASCO 202520.5.2025 22:30:00 CEST | Press release
Company’s AML drug program is focused on both newly diagnosed and relapsed/refractory FLT3-positive AML, overcoming major forms of resistance to FDA-approved FLT3 inhibitors, and outperforms other investigational inhibitors in a wide range of drug resistance models. CCM Biosciences, a diversified pharmaceutical discovery and development company, today announced the upcoming presentation of its next-generation FLT3 inhibitor drug program for acute myeloid leukemia (AML) at the 2025 Annual Conference of the American Society of Clinical Oncology (ASCO), taking place May 30 to June 3 in Chicago. Acute Myeloid Leukemia (AML) is the most severe form of leukemia with few treatment options, and a malignancy frequently driven by mutations in the FMS-like tyrosine kinase 3 (FLT3) gene. The FLT3 internal tandem duplication (ITD) and tyrosine kinase domain (TKD) mutations, particularly D835 and F691, appear in approximately 30% of AML patients, often leading to poor prognosis and resistance to exi
IonQ Partners with Sweden’s Einride to Develop Quantum Supply Chain and Quantum-Enhanced Logistics for Autonomous Driving Solutions20.5.2025 22:05:00 CEST | Press release
IonQ and Einride will collaborate to develop quantum solutions for fleet routing, logistics optimization, and supply chain solutionsIonQ’s investment will grow its European presence and reinforce commitment to building a quantum economy in Sweden and the European market IonQ (NYSE: IONQ), a leading commercial quantum computing and networking company, today announced an investment partnership with Einride, a leading global freight mobility company that provides digital, electric, and autonomous technology to explore how quantum computing can drive the next generation of fleet optimization and logistics. Together, IonQ and Einride will develop quantum applications that address large-scale routing and scheduling problems that have traditionally challenged classical computing. By combining IonQ’s advanced quantum systems with Einride’s expertise in autonomous fleet logistics, the two companies will work to unlock new levels of efficiency, reliability, and sustainability for the global frei
CCM Biosciences Announces Presentation of Data on its First-In-Class NSCLC Drug Program at ASCO 202520.5.2025 21:26:00 CEST | Press release
Company’s NSCLC drug program is focused on overcoming both mutational and non-mutational resistance to 3rd-generation EGFR inhibitors and outperforms other investigational 4th-generation inhibitors in a wide range of drug resistance models. CCM Biosciences, a diversified pharmaceutical discovery and development company, today announced the upcoming presentation of its 4th-generation EGFR inhibitor drug program for non-small cell lung cancer (NSCLC) at the 2025 Annual Conference of the American Society of Clinical Oncology (ASCO), taking place May 30 to June 3 in Chicago. NSCLC, which accounts for 80% of lung cancer, is the most common cause of cancer death worldwide. Epidermal growth factor receptor (EGFR)-activating mutations (Del19 or L858R) are major oncogenic drivers of NSCLC. EGFR-positive NSCLC accounts for approximately 30% of all diagnosed cases of NSCLC (a similar market size to PD-L1-positive NSCLC, which is addressed by the world’s top-selling drug, Keytruda®). The current s
NielsenIQ's Chief Technology Officer Mohit Kapoor Named Executive of the Year at Global Tech & AI Awards for Leading NIQ’s AI-Driven Tech Transformation20.5.2025 21:24:00 CEST | Press release
NielsenIQ (NIQ) is proud to announce that Mohit Kapoor, Chief Technology Officer, was named Executive of the Year at the inaugural Global Tech & AI Awards. This honor recognizes Mohit's exceptional leadership and visionary contributions to the tech industry, particularly in the realm of AI-powered consumer intelligence. "I am deeply honored to receive the Executive of the Year award at the Global Tech & AI Awards. This recognition is a testament to the incredible work and dedication of the entire NielsenIQ team,” said Mohit Kapoor, Chief Technology Officer, NIQ. “Together, we have redefined consumer and retail intelligence, leveraging AI to deliver unparalleled insights and drive meaningful change in the industry." Under Mohit's leadership, NIQ has adopted an AI-powered approach to its ambitious digital transformation which included a $400 million technology investment and the migration of its global client base onto Discover– a unified, cloud-based platform that seamlessly integrates
Strategic Partnership Between the Government of Morocco and TAQA Morocco, Nareva, ONEE and the Mohammed VI Investment Fund to Develop Key Power and Water Infrastructures in the Kingdom of Morocco20.5.2025 21:08:00 CEST | Press release
As part of the implementation of the commitments made in the joint declaration between His Majesty King Mohammed VI, may God Assist Him, and His Highness Sheikh Mohamed bin Zayed Al Nahyan, TAQA Morocco, in partnership with Nareva and the Mohammed VI Fund for Investment, has signed three memorandums of understanding and related development agreements with the Government of Morocco and ONEE. These agreements cover the development of structuring projects in the power, water and renewable energy sectors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250520313620/en/ Strategic Partnership Between the Government of Morocco and TAQA Morocco, Nareva, ONEE and the Mohammed VI Investment Fund to Develop Key Power and Water Infrastructures in the Kingdom of Morocco (Photo: AETOSWire) The program aims to strengthen the Kingdom's water and energy sovereignty through the development of flexible natural gas-based power generation capacit
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.
Besøg vores nyhedsrum